Sana Biotechnology, Inc.
SANA
$3.20
-$0.06-1.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 101.14M | 138.38M | 153.05M | 72.67M | 104.70M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.36M | 6.10M | 4.51M | 5.63M | 3.84M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.20M | 4.20M | 4.20M | 4.20M | 4.20M |
| Total Current Assets | 111.69M | 148.68M | 161.76M | 82.50M | 112.73M |
|
|
|||||
| Total Current Assets | 111.69M | 148.68M | 161.76M | 82.50M | 112.73M |
| Net Property, Plant & Equipment | 61.52M | 65.22M | 70.64M | 76.10M | 128.52M |
| Long-term Investments | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M |
| Goodwill | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M |
| Total Other Intangibles | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 563.00K | 3.17M | 3.22M | 3.22M | 4.39M |
| Total Assets | 373.59M | 416.89M | 435.43M | 361.65M | 445.47M |
|
|
|||||
| Total Accounts Payable | 2.12M | 1.67M | 1.86M | 2.27M | 989.00K |
| Total Accrued Expenses | 15.31M | 21.52M | 18.89M | 17.34M | 19.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.28M | 15.34M | 14.77M | 13.83M | 13.00M |
| Total Finance Division Other Current Liabilities | 53.56M | 40.20M | -- | -- | -- |
| Total Other Current Liabilities | 53.56M | 40.20M | -- | -- | -- |
| Total Current Liabilities | 86.27M | 78.73M | 35.51M | 33.44M | 33.16M |
|
|
|||||
| Total Current Liabilities | 86.27M | 78.73M | 35.51M | 33.44M | 33.16M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 67.35M | 70.92M | 74.97M | 71.66M | 78.31M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 100.74M | 106.36M | 129.64M | 133.99M | 124.92M |
| Total Liabilities | 254.35M | 256.01M | 240.12M | 239.09M | 236.39M |
|
|
|||||
| Common Stock & APIC | 2.02B | 2.01B | 1.99B | 1.87B | 1.86B |
| Retained Earnings | -1.90B | -1.85B | -1.79B | -1.75B | -1.65B |
| Treasury Stock & Other | -2.00K | 28.00K | 21.00K | -- | -- |
| Total Common Equity | 119.24M | 160.88M | 195.31M | 122.56M | 209.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 119.24M | 160.88M | 195.31M | 122.56M | 209.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 119.24M | 160.88M | 195.31M | 122.56M | 209.08M |
|
|
|||||